http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0404938-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39277fc0fe76ac7469ebec0d93d7d8ce |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C401-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C401-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00 |
filingDate | 1989-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8d9402a4f96eba6a06e597359071b01 |
publicationDate | 1991-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0404938-A1 |
titleOfInvention | 1 beta,7,8-TRIHYDROXYVITAMIN D 2, 1 beta,7,8-TRIHYDROXYVITAMIN D 3 OR THEIR DERIVATIVES, AND PROCESS FOR THEIR PREPARATION |
abstract | Novel compounds represented by formula (II) are disposed. They can be easily converted into a fragment corresponding to ring A to be used in a process for binding a fragment corresponding to ring A to fragments corresponding to rings C and D by the oxidative cleavage of the C 7 -C 8 bond according to a known method. The novel compounds of formula (II) can be obtained by allylic oxidation of the compound of formula (I) to directly introduce one oxygen-functional group into C 1 -position. |
priorityDate | 1988-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 72.